Market Street Capital Brings Discipline to Healthcare Financing

Healthcare and diagnostics operators are confronting a convergence of pressures: consolidation, reimbursement uncertainty, and more selective sponsors. In this climate, the structure of a capital raise can be as critical as the underlying business. Market Street Capital, a boutique capital markets and financial advisory firm, specializes in guiding established middle-market businesses through pivotal development moments, focusing on companies with enterprise values from $10 million to $1 billion. The firm’s different platforms provide capital markets and advisory guidance, and with more than $3 billion in completed transactions, Market Street offers advisory and capital markets services for healthcare financings.

Reimbursement is a primary driver of change in healthcare financing. Clinical laboratories illustrate the challenge: the Consolidated Appropriations Act of 2026, signed Feb. 3, delayed Medicare lab fee schedule cuts through 2026. However, according to the Centers for Medicare & Medicaid Services (“CMS”), payments for affected tests may decline beginning in 2027, subject to a… This uncertainty forces operators to rethink capital strategies, making expert advisory services like those from Market Street Capital increasingly vital.

Market Street Capital’s expertise spans capital markets and advisory, helping clients navigate complex financings. With over $3 billion in completed transactions, the firm is a trusted partner for middle-market healthcare companies. As reimbursement pressures mount and consolidation accelerates, Market Street’s disciplined approach to capital structuring can mean the difference between thriving and merely surviving. For more details, read the full article here.